Some studies with 3xTg‐AD mice carrying mutant APP and MAPT transgenes together with a Psen1 knock‐in mutation have shown that HFD treatment increases brain Aβ levels with an exacerbated cognitive decline (Barron et al., 2013; Vandal et al., 2014). The gene discussed is APP; the disease is Alzheimer disease.